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Abstract. 
 
Neuronal differentiation and function re-
quire extensive stabilization of the microtubule cyto-
skeleton. Neurons contain a large proportion of micro-
tubules that resist the cold and depolymerizing drugs 
and exhibit slow subunit turnover. The origin of this 
stabilization is unclear. Here we have examined the 
role of STOP, a calmodulin-regulated protein previ-
ously isolated from cold-stable brain microtubules. We 
find that neuronal cells express increasing levels of 
STOP and of STOP variants during differentiation. 
These STOP proteins are associated with a large pro-
portion of microtubules in neuronal cells, and are con-
centrated on cold-stable, drug-resistant, and long-lived 
polymers. STOP inhibition abolishes microtubule cold 
and drug stability in established neurites and impairs 
neurite formation. Thus, STOP proteins are responsi-
ble for microtubule stabilization in neurons, and are ap-
parently required for normal neurite formation.
Key words: neuron • STOP • E-STOP • microtubule-
associated protein • calmodulin
 
N
 
eurons
 
 establish connections with other cells over
long distances. To do this, the rounded neuronal
cell body produces axodendritic extensions. Mi-
crotubules play a key role in this remarkable morphoge-
netic process (Yamada et al., 1970; Drubin et al., 1985;
Burgoyne, 1991). A salient feature of neuronal microtu-
bules, thought to be intimately related to their morphoge-
netic function, is the stability of their assembly state. Neu-
rons contain a high proportion of stable microtubules that
resist exposure to cold temperature and to depolymerizing
drugs (Webb and Wilson, 1980; Morris and Lasek, 1982;
Black et al., 1984; Brady et al., 1984; Baas et al., 1994). As
an apparent consequence of polymer stabilization, a large
proportion of neuronal microtubules exhibit slow subunit
turnover (Lim et al., 1989; Okabe and Hirokawa, 1990;
Takeda et al., 1995; Li and Black, 1996). The presence of
abundant subsets of long-lived polymers in nerve tissues
causes a characteristic accumulation of posttranslationally
modified tubulin molecules (for review see Cambray-
Deakin, 1991; Paturle-Lafanechère et al., 1994). Stabilized
microtubules are apparently required for generating and
maintaining neuronal morphology and function (Baas and
Heidemann, 1986; Baas and Black, 1990; Baas and Ah-
mad, 1992). Defects in microtubule stabilization may play
a significant role in neuronal pathologies such as Alz-
heimer’s disease (for review see Mandelkow et al., 1995).
Polymer stabilization is an obvious massive property of
neuronal microtubules, yet the origin of microtubule stabi-
lization is unclear. Microtubules interact with a multiplic-
ity of cell components, and it is unknown whether microtu-
bule cold stability, microtubule drug resistance, and slow
microtubule turnover have a common origin or arise from
the action of different factors. Over the past decades,
microtubule effectors have mainly been sought among
MAPs
 
1
 
 (microtubule-associated proteins; for reviews
see  Hirokawa, 1994; Mandelkow and Mandelkow, 1995).
MAP2 and tau are two well-characterized effectors of mi-
crotubule stability in neurons. However, MAP2 and tau do
not account for all the stability properties of neuronal mi-
crotubules. For instance, these MAPs do not confer cold
stability to microtubules (Pirollet et al., 1983; Baas et al.,
1994). Therefore, provided that MAPs are indeed the
principal factors responsible for the stabilization of brain
microtubules, at least one or several other MAPs must be
involved in the stabilization of neuronal microtubules.
One candidate for such a stabilizing function is STOP (sta-
ble tubule-only polypeptide).
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STOP was initially isolated from preparations of rat
brain cold-stable microtubules (Job et al., 1982), and was
found to be a calmodulin-binding protein with potent mi-
crotubule-stabilizing capacity in vitro (Job et al., 1981; Job
et al., 1982; Margolis et al., 1986). Recently the STOP
cDNA has been cloned (Bosc et al., 1996). Expression of
the cloned STOP cDNA in human cervical carcinoma cells
induced a microtubule stable state (Bosc et al., 1996) remi-
niscent of that observed in neurons. These results raised
the possibility that STOP may be a major factor responsi-
ble for microtubule stabilization in neurons, and hence
may be important for neuronal morphogenesis. The present
work was undertaken to assess the validity of this hypothe-
sis. We tested to see whether STOP was associated with
microtubules in neuronal cells, whether such an associa-
tion occurred preferentially on stable polymers, and
whether the inhibition of STOP suppressed microtubule
stability. We further assessed the effect of STOP inhibition
on neurite formation in cells undergoing neuronal differ-
entiation.
We find that neuronal cells express increasing levels of
several STOP variants during differentiation. STOP pro-
teins are associated with a large proportion of axonal mi-
crotubules. STOP-associated polymers are also cold-sta-
ble, nocodazole-resistant, and contain elevated levels of
posttranslationally modified tubulin. STOP inhibition by
microinjected STOP antibodies specifically abolishes mi-
crotubule cold and drug stability in neurites, providing di-
rect evidence that microtubule association with STOP pro-
teins is the cause of microtubule stabilization. Furthermore,
neuronal cells microinjected with STOP antibodies or ex-
posed to STOP antisense oligonucleotides during differen-
tiation show impaired neurite outgrowth.
These data show that microtubule stabilization in neu-
rons is mainly due to the action of STOP proteins, and that
STOP proteins are required for normal neurite formation.
 
Materials and Methods
 
Cell Culture
 
Dorsal root ganglia (DRG) were dissected from 14-d-old rat embryos and
plated either on glass coverslips or on 35-mm plastic culture dishes coated
with 100 
 
m
 
g/ml poly-
 
l
 
-ornithine (Sigma Chemical Co., St Louis, MO) and
10 
 
m
 
g/ml laminin (Sigma Chemcial Co.). DRG were cultured in N2 me-
dium (Bottenstein and Sato, 1979) supplemented with 100 ng/ml NGF
(Sigma Chemcial Co.). Undifferentiated PC12 cells were grown in RPMI
1640 (GIBCO BRL, Paisley, Scotland) supplemented with 5% FCS and
5% horse serum, and were subcultured every 3 d. For NGF treatment,
PC12 cells were grown on 100 
 
m
 
g/ml poly-
 
l
 
-ornithine, 10 
 
m
 
g/ml laminin–
coated glass coverslips, or 35-mm plastic culture dishes in Roswell Park
Memorial Institute 1640 supplemented with 1% FCS, 1% horse serum,
and 100 ng/ml NGF.
 
STOP and Tubulin Antibodies
 
Two rabbit polyclonal antibodies—23N and 23C—were raised against
nonoverlapping synthetic peptides corresponding to the NH
 
2
 
-terminal do-
main (23N) or the COOH-terminal domain (23C) of the rat brain STOP
central repeat motif (Bosc et al., 1996). The immunogenic peptides were
PAAGKASGADQRDTRRKAG (amino acids [aa] 222–240 of the STOP
sequence) and TRTEGHEEKPLPPAQSQTQEGG (aa 246–267 of the
STOP sequence) for the 23N and 23C antibodies, respectively. Each pep-
tide was conjugated to keyhole lympet hemocyanin and then injected into
rabbits. Sera 23N and 23C were affinity-purified against the corresponding
peptide. Monoclonal antibody 296 was a previously described STOP anti-
body (Pirollet et al., 1989) whose epitope on STOP has recently been lo-
calized in the COOH-terminal repeat domain of the protein. Detyrosi-
nated tubulin (Glu-tubulin) antibody (L3) and 
 
D
 
2-tubulin antibody (L7)
were as previously described (Paturle-Lafanechère et al., 1994). A rat
monoclonal antibody (YL 1/2) against the tyrosinated form of tubulin
(Tyr-tubulin) was kindly provided by Dr. J.V. Kilmartin. Mouse mAb
against 
 
b
 
-tubulin (clone TUB 2.1) was obtained from Sigma Chemical Co.
(St. Louis, MO).
 
Preparation of Cell and Tissue Extracts
 
Brains from adult rats or from 14-d-old rat embryos, and cerebella from
2-, 10-, or 20-d-old rats were homogenized in 100 mM MES, 1 mM EGTA,
and 1 mM MgCl
 
2
 
 buffer (pH 6.75; 0.75/1, vol/wt) containing protease in-
hibitors (Complete™
 
 
 
tablets from Boehringer GmbH, Mannheim, Ger-
many). The homogenates were centrifuged at 200,000 
 
g
 
 for 10 min at 4
 
8
 
C.
Supernatants were then harvested, supplemented with SDS/PAGE sam-
ple buffer (Laemmli, 1970), and boiled for 3 min. DRG and PC12 cells
were extracted in 1% boiling SDS. After cooling, extracts were centri-
fuged at 200,000 
 
g
 
 for 10 min at 4
 
8
 
C. The supernatants were supplemented
with SDS/PAGE sample buffer and then boiled again for 3 min.
 
SDS-Polyacrylamide Gels and Immunoblotting
 
SDS-PAGE was performed according to Laemmli (1970). For immuno-
blotting, proteins were subsequently transferred onto nitrocellulose ac-
cording to Towbin et al. (1979). Nitrocellulose membranes were processed
as previously described (Lieuvin et al., 1994). The 23C, 23N, and mAb 296
primary STOP antibodies were diluted to 1/5,000, 1/10,000 and 1/5,000, re-
spectively. YL1/2, L3, and L7 primary tubulin antibodies were diluted to
1/1,000, 1/100,000 and 1/100,000 respectively. Goat anti–rabbit (Tago Im-
munologicals, Burlingame, CA), anti–mouse (Cappel Laboratories, Mal-
vern, PA), and donkey anti-rat (Jackson ImmunoResearch Laboratories,
Inc., West Grove, PA) HRP-coupled secondary antibodies were diluted to
1/5,000.
 
Immunofluorescence Microscopy
 
Ganglionic explants or PC12 cells grown on coverslips were fixed in cold
methanol and processed for immunofluorescence as in Lieuvin et al.
(1994). Rat cerebellum sections were prepared and processed as in
Paturle-Lafanechère et al. (1994). The affinity-purified 23C primary
STOP antibody was diluted to 1/50. L3 and L7 primary tubulin antibodies
were diluted to 1/1,000. TUB 2.1 primary tubulin antibody was diluted to
1/100. Goat anti-rabbit Cy3-coupled secondary antibodies (Jackson Im-
munoResearch Laboratories, Inc.) were diluted to 1/1,000. Goat anti–
mouse FITC-coupled secondary antibodies (Jackson ImmunoResearch
Laboratories, Inc.) were diluted to 1/250. Images were digitalized using an
RTE-CCD-1317-K/1 camera (Princeton Instruments Inc., Trenton, NJ)
and IPLab Spectrum software (Signal Analytics Co., Vienna, VA).
 
Electron Microscopy
 
For control experiments, ganglionic explants on coverslips were washed in
PBS buffer and permeabilized by a 3-min immersion in 2 ml of warm 100 mM
Pipes, 1 mM EGTA, 1 mM MgCl
 
2
 
, pH 6.65 buffer (PEM buffer) contain-
ing 0.1% Triton X100 (vol/vol) and 10% glycerol (vol/vol). Coverslips
were rinsed once in PEM buffer containing 10% glycerol (vol/vol), and
explants were then fixed for 3 min in the same buffer supplemented with
0.5% 1-ethyl-3-(3-dimethylamino-propyl)carbodiimide (vol/wt; Sigma
Chemical Co.) and 0.1 mM GTP. Explants were then further processed
for immunoelectron microscopy according to Baas and Black (1990). Ex-
plants were successively washed for 3 min at room temperature in PEM,
10% glycerol (vol/vol), and for 1 min in 10 mM Tris, 140 mM NaCl, pH 7.6
(TBS1), 1% BSA (vol/wt). Explants were further incubated for 1 h at
room temperature with a primary antibody. Primary antibodies (23C
STOP antibody, Glu-tubulin antibody, Tyr-tubulin antibody, and 
 
D
 
2-
tubulin antibody) were diluted to 1/20 in TBS1, 1% BSA (vol/wt). The ex-
plants were subsequently washed three times in 20 mM Tris, 140 mM
NaCl, pH 8.2 (TBS2), 0.1% BSA (vol/wt), and incubated for 1 h at room
temperature with appropriate 5-nm gold-coupled secondary antibodies
(British BioCell International, Cardiff, United Kingdom). Secondary anti-
bodies were diluted to 1/2 in TBS2, 0.1% BSA (vol/wt). After three
washes in TBS2 buffer, explants were postfixed for 10 min in 0.1 M ca-
codylate (Taab Laboratories, Aldermaston, United Kingdom), 1% glu-
taraldehyde (Taab), and 2 mg/ml tannic acid (Mallinckrodt Inc., Paris, 
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KY). Preparations were washed in 0.1 M cacodylate for 3 min and incu-
bated in 0.1 M cacodylate supplemented with 2% osmic acid (vol/vol;
Taab) for 10 min. After successive ethanol dehydration, DRG prepara-
tions were embedded in Epon (CIPEC, Paris, France) according to Pig-
not-Paintrand (1992). Frontal ultrathin sections were made using a dia-
mond knife (Diatome Ltd., Biel, Switzerland) on an UltraCut S
ultramicrotome (Reichert-Jung, Vienna, Austria) and collected on form-
var (Taab)-coated slot grids (ref. 26310; Touzart & Matignon, Vitry-sur-
Seine, France). Samples were observed on a 1200 EX II electron micro-
scope (Jeol Ltd., Akishima, Japan).
For nocodazole treatment, explants were exposed for 30 min to 20 
 
m
 
M
nocodazole before processing for EM. For cold treatment, explant cells
were permeabilized in 4
 
8
 
C PEM-Triton-glycerol buffer and left on ice for
30 min before fixation and processing for EM. Microtubule cold stability
tests yielded similar results when performed on intact or permeabilized
cells (Lieuvin et al., 1994). For the present study, cell permeabilization
was used since (
 
a
 
) it allows nearly instantaneous selection of stabilized
polymers without superimposed effects of cell regulations, and (
 
b
 
) mini-
mizes the possibility of STOP redistribution from depolymerizing labile
polymers onto surviving stable polymers.
PC12 cells were fixed and processed for electron microscopy examina-
tion as in Yu and Baas (1995).
 
Assay of Microtubule Stability and Antibody Labeling in 
Electron Microscopy Experiments
 
For each condition, three independent ganglionic explants on different
coverslips were used and processed in parallel for immunoelectron mi-
croscopy. Two sets of ten serial ultrathin frontal sections were performed
for each embedded sample: one in the proximal region and one in the dis-
tal region of DRG cell axons. The proportions of drug- and cold-stable
microtubules relative to control microtubules were determined as the
ratio of the number of microtubules present per grid mesh in cold- or
drug-treated preparations to the corresponding value in control untreated
preparations. Section five of each embedded sample was analyzed. The
number of polymers present in a mesh randomly selected within the part
of the grid containing axons and in two adjacent meshes was determined
on each microscopy grid. The variance of the estimated proportions of
cold-stable and cold-labile polymers was calculated according to the clas-
sical formula: 
For quantification of antibody labeling with STOP or tubulin antibodies,
sections 4–6 of each set were analyzed. On each microscopy grid, ten dif-
ferent microscopy fields were examined. Microtubule labeling was quanti-
fied by counting the number of gold particles observed along each poly-
mer in the field. Results were expressed in numbers of gold particles per
500 nm of microtubule length. Estimated values of the average number of
gold particles present on labile microtubules was determined as follows: 
where CL, CS, and T represent the average number of gold particles
per unit of polymer length in cold-labile, cold-stable, and total microtu-
bules, respectively.
 
 P 
 
represents the proportion of cold-stable microtu-
bules. In Table I, a
 
 P 
 
value of 50% corresponding to a conservative esti-
mate of microtubule cold stability (see text) has been used. Using such a
 
 P
 
value, CL 
 
5 
 
2T 
 
2 
 
CS and VarCL 
 
5 
 
4VarT 
 
1
 
 VarCS. These estimates rely
on the hypothesis that the composition of stable microtubules does not
change during labile polymer disassembly. This condition was almost cer-
tainly fulfilled during cold stability tests. STOP redistribution was a re-
mote possibility during the cold stability test as designed in the present
study (see above). Microtubule detyrosination during concomitant cell ly-
sis and exposure to cold temperature is, in our experience, not detectable.
The situation was different in the case of the nocodazole stability test: dur-
ing the test, STOP proteins could shift from disassembling microtubules to
surviving polymers, and in this case the possibility of significant action of
the tubulin carboxypeptidase could not be totally excluded.
 
cDNA Cloning
 
An oligo(dT)-primed fetal rat brain cDNA library (CLONTECH Labora-
tories, Inc., Palo Alto, CA) was screened using a 
 
32
 
P-labeled probe corre-
sponding to nucleotides 1138–1935 of the adult rat brain STOP cDNA
(Bosc et al., 1996). Screening was performed using standard procedures
Var A/B () 1/B
2 VarA A/B
2 + VarB ´ [] =.
CL T P –C S ´ () 1P – () ¤ =
 
(Sambrook et al., 1989). A total of 22 overlapping clones was obtained.
One clone contained the entire coding sequence corresponding to a novel
STOP isoform (see text).
 
In Vitro Translation of Early (E)-STOP cDNA and 
Assay of E-STOP Binding to Microtubules
 
Construction of E-STOP expression vector was done by replacing frag-
ment SacII/ EcoICR I (nucleotides [nt] 997–2843) of STOP cDNA in
pSG5-STOP construct (Bosc et al., 1996) by fragment Sac II/Pme I (nt
833–2401) of E-STOP cDNA. The resulting construct (pSG5-E-STOP)
was used for in vitro translation of E-STOP and microtubule-binding as-
says as in Bosc et al. (1996).
 
Microinjection and Analysis of Fused PC12 Cells
 
To allow microinjection experiments, PC12 cells were chemically fused:
PC12 cells were rinsed in RPMI 1640 supplemented with 20 mM Hepes
(GIBCO BRL), centrifuged, and resuspended in 1 ml of polyethylene gly-
col 1500 (Boehringer GmbH) for 1 min at 37
 
8
 
C. The cell suspension was
then diluted in 10 ml of RPMI 1640, 20 mM Hepes, and incubated for 5
min at 37
 
8
 
C. Fused cells were centrifuged for 5 min at 300 
 
g
 
, resuspended
in culture medium, and plated on Cellocate coverslips (Eppendorf-
Netheler-Hinz GMBH, Hamburg, Germany) coated with 100 
 
m
 
g/ml poly-
 
l
 
-ornithine and 10 
 
m
 
g/ml laminin. Cells were pressure-injected using a
5171 micromanipulator (Eppendorf-Netheler-Hinz GmbH), a 5246 trans-
jector (Eppendorf-Netheler-Hinz GmbH), and an Axiovert 35M micro-
scope (Carl Zeiss, Oberhocken, Germany).
Fused PC12 cells were cultured for 48–72 h in the presence of NGF be-
fore assay of antibody effect on microtubule stability. Differentiated fused
cells were microinjected with 2 mg/ml affinity-purified 23C or 23N STOP
antibodies, or with control IgGs at the same protein concentration. These
control IgGs were purified from sera of nonimmunized rabbits. After mi-
croinjection and an additional 2–30 h of culture in the presence of NGF,
some cells were exposed for 30 min to cold temperature or to 20 
 
m
 
M no-
codazole. Subsequent assay of cell microtubule content was as in Lieuvin
et al. (1994): after treatment, cells were extracted for 1 min in a large vol-
ume of PEM buffer containing 0.1% Triton X100 (vol/vol) and 10% glyc-
erol (vol/vol) to remove soluble tubulin, and were then prepared for im-
munofluorescence analysis of the remaining polymeric tubulin using mAb
TUB 2.1.
To assess STOP antibody effect on neurite outgrowth, fused cells were
microinjected either with the 23C antibody or with control IgGs after 1 d
of culture in the presence of NGF. After an additional 24–36 h of culture
in the presence of NGF, cells were then processed for immunofluores-
cence analysis. Microinjected IgGs were reacted with a Cy3-coupled IgG
antibody, and tubulin was stained with mAb TUB 2.1 and FITC-coupled
secondary antibody. Microinjected and control cells were analyzed for the
presence of neurite extensions.
 
Transfection of PC12 Cells with 
Antisense Oligonucleotides
 
Five antisense oligonucleotides corresponding to nucleotide sequences lo-
cated in the central repeat domain of STOP were designed based upon rat
brain STOP cDNA sequence (Bosc et al., 1996): ON1as (nt 1172–1189),
ON2as (nt 1231–1248), ON3as (nt 1236–1253), ON4as (nt 1536–1553), and
ON5as (nt 1843–1860). Control scrambled oligonucleotides were as fol-
lows: ON1sc (5
 
9
 
 AGCCGAGCCCTGTGTCTG 3
 
9
 
), ON2sc (5
 
9
 
 AATGC-
CTCGTCGCTCCGC 3
 
9
 
), ON3sc (5
 
9
 
 CGCGACCGCTTTGGTTCG 3
 
9
 
),
ON4sc (5
 
9
 
 GGGGGCTGGGACGGCGAG 3
 
9
 
), and ON5sc (5
 
9
 
 TCT-
CTCGCCGTCGTTCCC 3
 
9
 
). Control sense oligonucleotides (ON1se,
ON2se, ON3se, ON4se, and ON5se) were synthesized as the reverse com-
plement of the antisense oligonucleotides. PC12 cells were transfected
with antisense, sense, or scrambled oligonucleotides using DOTAP
 
 
 
(Boeh-
ringer Mannheim GmbH) as a transfection reagent according to the man-
ufacturer’s instructions. For controls, PC12 cells were exposed to DOTAP
alone. Cells were observed after 24–36 h of NGF and oligonucleotide
treatment, and were analyzed for the presence of neurite extensions using
phase contrast microscopy. Cells were scored as positive if they exhibited
extensions longer than one cell body diameter. In some experiments, cells
were further immunostained with tubulin antibodies for detailed analysis
of neurite extensions. Each experiment involved parallel examination of
cells treated with DOTAP alone, of cells exposed to one antisense oligo- 
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nucleotide, and of cells treated with the corresponding sense or scrambled
oligonucleotides. For each condition cells grown on three different cover-
slips were examined. Three microscopy fields were randomly selected on
each coverslip. A total of 
 
z
 
800–1000 cells was screened per condition.
Each experiment was run at least in triplicate.
 
Results
 
To investigate the distribution of STOP, we used explants
of dorsal root ganglia (DRG) from rat embryos. Ganglion
explants sprout dense radial arrays of axons during DRG
cell differentiation in vitro, and provide a convenient sys-
tem for ultrastructural studies of statistically significant
populations of microtubules (Baas and Black, 1990).
 
STOP Expression in DRG Cells and Comparison with 
Pattern of Expression In Vivo
 
DRG cells were first tested for the pattern of STOP ex-
pression on immunoblots of cell extracts (Fig. 1). For this
we used three different primary STOP antibodies directed
against distinct epitopes of the protein. STOP contains a
central repeat domain and a carboxy terminal repeat do-
main (Fig. 1; Bosc et al., 1996). Two antibodies (23C and
23N) were directed against nonoverlapping peptides de-
rived from the amino acid sequence of STOP central re-
peat. The third antibody (mAb 296) was directed against
epitopes located in the STOP carboxy terminal repeat do-
main (for details see Materials and Methods). Extracts
from adult rat brain and extracts from embryonic rat brain
were analyzed in parallel with DRG cell extracts.
In DRG cell extracts the two central repeat antibodies
(23C and 23N) reacted with a major 84-kD polypeptide
not recognized by mAb 296 (Fig. 1 
 
A
 
). By contrast, the
standard adult rat brain STOP has a higher mass and re-
acts with all three STOP antibodies (Fig. 1 
 
A
 
). The 84-kD
polypeptide was present in cell extracts after 3 d of cell dif-
ferentiation, and was enhanced after 10 d of cell differenti-
ation. The 84-kD polypeptide was present as a minor band
in adult rat brain extracts, but was the dominant STOP an-
tigen in embryonic rat brain (Fig. 1 
 
A
 
). We have chosen to
call this 84-kD polypeptide E-STOP to denote its early ap-
pearance during development. As a result of screening an
embryonic rat brain cDNA library, we have determined
the nucleotide sequence of the E-STOP cDNA and the
corresponding protein sequence (GenBank/EMBL/DDBJ
accession no. AJ002556). E-STOP differs from the stan-
dard adult STOP by insertion of an additional central re-
peat and by deletion of a COOH-terminal amino acid
stretch (amino acid [aa] 615–952 of the standard STOP
protein; Fig. 1 
 
B
 
). This COOH-terminal domain contains
the carboxy terminal STOP repeats recognized by mAb
296. Despite its lack of COOH-terminal repeats, E-STOP
shows calmodulin-binding and microtubule-stabilizing ac-
tivity comparable to adult STOP. As adult STOP (Bosc
et al., 1996), E-STOP binds to calmodulin columns in a
Ca
 
2
 
1
 
-dependent manner, cosediments with microtubules
in microtubule-binding assays, and induces microtubule
stabilization when expressed in cells normally devoid of
stable microtubules (data not shown).
In addition to E-STOP, 10-d–differentiated DRG cell
extracts contained standard adult STOP (Fig. 1 
 
A
 
). DRG
cell extracts also contained a 62-kD polypeptide recog-
nized by the two central repeat antibodies (23C and 23N;
Fig. 1 
 
A
 
), and by STOP antibodies 22 and 136 directed
against epitopes located upstream (aa 160–174) and down-
stream (aa 485–504) of STOP central repeats, respectively
(data not shown). This 62-kD STOP antigen was also
present in embryonic brain extracts (Fig. 1 
 
A
 
). It may be a
proteolysis product of STOP, or it may be a third STOP
isoform that was not further characterized in the present
study.
The pattern of STOP expression in DRG cells suggested
strong correlation between neuronal cell differentiation
and STOP expression. To test whether these conclusions
applied to in vivo situations, we assayed STOP expression
and distribution in developing rat cerebellum. Immunoblot
analysis showed similar patterns of STOP and E-STOP
expression during development in cerebellum as in DRG
cells (Fig. 2 
 
A
 
). In developing cerebellum, neuronal cells at
different stages of differentiation are organized in distinct
cell layers. In 2-d-old rats, dividing neuronal cells are still
present in the external germinal layer (EGL), whereas
cells in the underlying molecular layer (ML) have under-
gone neuronal differentiation and grown neurite exten-
sions (Burgoyne and Cambray-Deakin, 1988). STOP
staining of cerebellum sections from 2-d-old rat cerebel-
lum showed absence of detectable STOP staining in the
EGL, while STOP staining was intense in the adjacent ML
(Fig. 2, 
 
B
 
 and 
 
C
 
). These results show strong correlation be-
tween neuronal differentiation and STOP expression in
vivo. At later stages of cerebellum development, patterns
of STOP staining were essentially identical to those previ-
ously determined in the case of 
 
D
 
2-tubulin, a known
marker of microtubule neuronal differentiation (data not
shown; Paturle-Lafanechère et al., 1994).
 
STOP Proteins are Associated with a Large Proportion 
of Microtubules in DRG Cells Axons
 
STOP proteins were localized in the axons of DRG cells
using both immunofluorescence and immunoelectron mi-
croscopy. We used the 23C STOP antibody which only re-
acts with STOP proteins in DRG cells (see above). An im-
munofluorescence image of DRG cell axons stained with
the 23C STOP antibody is shown in Fig. 3 
 
A
 
. Axons were
brightly stained, and the staining was apparently homo-
geneous along the whole axonal length. Although this
showed that STOP proteins were widely distributed in ax-
ons, the resolution of immunofluorescence microscopy
was not sufficient to assess STOP association with micro-
tubules within the axons. Therefore, we examined the dis-
tribution of STOP proteins using immunoelectron micros-
copy. Processing DRG cells for EM examination involved
a cell permeabilization step (see Materials and Methods).
We verified by immunoblot assays that no detectable
amount of STOP proteins was eliminated during this per-
meabilization step (data not shown). When stained with
the 23C antibody and a gold-coupled secondary antibody,
DRG cell axons showed specific microtubule labeling (Fig.
3 
 
B
 
). We determined the number of gold particles per unit
of microtubule length in a series of microscopic images, an
example of which is shown in Fig. 3 
 
B
 
. This analysis was
performed separately for the proximal and distal parts of
axons. Results were similar in both parts of axons, and are 
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shown in the case of distal microtubules (Fig. 3 
 
C
 
, 
 
black
bars
 
). Over 60% of the microtubules were associated with
more than 10 gold particles per 500 nm of microtubule
length. In parallel experiments in which DRG cell axons
were labeled with the secondary antibody alone, we never
observed more than 4 gold particles per 500 nm of micro-
tubule length. These data showed that in DRG cells, a
large proportion of axonal microtubules had significant
STOP staining, and were therefore associated with STOP
proteins.
 
STOP Proteins are Concentrated on Cold-stable 
and Drug-resistant Microtubules in DRG Cells
 
To investigate the relationship between STOP distribution
and microtubule stability, differentiated DRG cells treated
with cold or nocodazole or untreated were compared for
the presence of STOP proteins on microtubules. Treated
and untreated DRG cells were processed for immunoelec-
tron microscopy. A comparison between treated or un-
treated cells for microtubule numbers on grids showed
that the distal part of DRG cell axons contained 57 
 
6 
 
6%
(percent 
 
6 
 
SD) cold-stable microtubules and 41 
 
6 
 
6%
nocodazole-resistant microtubules (for details see Materi-
als and Methods). Similar proportions of stable microtu-
bules were observed in the proximal part of axons. These
estimates were in good agreement with previously pub-
lished data, reporting 60% cold-stable microtubules and
50% nocodazole-resistant microtubules in differentiated
DRG cells (Sekimoto et al., 1995). Microtubule STOP la-
beling was quantified on distal sections of DRG cell axons.
In untreated cells, microtubules (total microtubules) were
decorated on average with 12.8 
 
6 
 
0.3 (mean 
 
6 
 
SEM) gold
particles per 500 nm of polymer length (Fig. 3 
 
C
 
 and Table
I). Microtubule labeling was independent of the number
of polymers present in the microscopy field (
 
r
 
 
 
5 
 
0.08,
 
 P 
 
.
 
0.05). In cells exposed to cold temperature, microtubules
(cold-stable microtubules) were associated with an aver-
Figure 1. STOP expression
in DRG cells. (A) Immuno-
blot analysis of STOP ex-
pression. Proteins from 3-d
differentiated DRG cells
(lane  1), 10-d differentiated
DRG cells (lane 2), adult rat
brains (lane 3), and embry-
onic rat brains (lane 4) were
run on 7.5% SDS gels. 20 mg
of DRG cell extract proteins
were loaded onto the gel.
Amounts of loaded brain
proteins were adjusted to
equilibrate brain and DRG
cell STOP signals. Proteins
were immunoblotted with
polyclonal STOP antibodies
23C and 23N (central repeat
antibodies), and with mono-
clonal STOP antibody 296 (COOH-terminal repeat antibody) as indicated. The bands corresponding to STOP and E-STOP are indi-
cated. Size markers are in kD. (B) Schematic representation of STOP and E-STOP showing domain structure of the two proteins. Both
proteins contain a central domain composed of 5 (STOP) or 6 (E-STOP) repeats. STOP also contains a COOH-terminal repeat domain
that is lacking in E-STOP. The E-STOP sequence ends at a position corresponding to aa 614 in the STOP sequence (Bosc et al., 1996).
The E-STOP sequence data are available from GenBank/EMBL/DDBJ under accession no. AJ002556.
Figure 2. STOP expression during
postnatal development of the rat
cerebellum. (A) Immunoblot analy-
sis of STOP expression in the cere-
bellum. Proteins from 2-d, 10-d, and
20-d-old rat were run on 7.5% SDS
gels. 2 mg of cerebellum extract pro-
teins were loaded onto the gel. Pro-
teins were immunoblotted with
polyclonal STOP antibody 23C.
The bands corresponding to STOP
and E-STOP are indicated. Size
markers are in kD. (B and C) Im-
munofluorescence staining of the
cerebellar cortex. Sections of 2-d
aged rat cerebellum were stained with polyclonal STOP antibody 23C (B); (C) corresponding DNA staining with Hoechst. EGL,
external germinal layer, ML, molecular layer. Bar, 40 mm. 
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age number of 21.4 
 
6 
 
0.6 gold particles per 500 nm of
polymer length (Fig. 3 
 
C
 
 
 
and Table I). In cells exposed to
nocodazole, microtubules (drug-stable microtubules) were
associated on average with 22.0 
 
6 
 
0.6 gold particles per
500 nm of polymer length (Fig. 3 C). These results showed
that cold-stable microtubules and drug-stable microtu-
bules were highly enriched in STOP protein as compared
with total microtubules. However, the total microtubule
population was heterogeneous, being comprised of stable
and labile polymers. Obviously one would like to compare
homogeneous populations of stable or labile microtubules.
Labile microtubules could not be examined directly, but
estimates of the STOP content of labile polymers could be
derived from experimental data in the case of cold-labile
polymers (see Materials and Methods). The estimated
mean number of gold particles per 500 nm of polymer
length present on cold-labile microtubules amounted to
4.2 6 0.8 gold particles (Table I), a value close to that ob-
tained with secondary antibody alone. Such a value indi-
cated that most cold-labile microtubules contained little or
no STOP protein, and suggested a very tight relationship
between microtubule association with STOP proteins and
microtubule cold stability.
In DRG Cells, Microtubule Cold Stability is Tightly 
Related to Microtubule Detyrosination
It is unknown whether cold stability, a microtubule prop-
erty tightly related to microtubule association with STOP
proteins (see above), is also related to slow microtubule
turnover in neurons (Baas et al., 1994). To test whether
cold-stable microtubules in DRG cells corresponded to
the nondynamic polymers normally present in neuronal
cells, we examined cold-stable polymers for their detyrosi-
nated tubulin content. Detyrosinated tubulin differs from
normal tubulin by deletion of the COOH-terminal ty-
rosine residue of a-tubulin, and is known to accumulate in
nondynamic polymers (Kreis, 1987; Schulze et al., 1987;
Wehland and Weber, 1987; Bulinski and Gundersen,
1991). Detyrosinated tubulin (Glu-tubulin) is generated
from normal tyrosinated tubulin (Tyr-tubulin) in microtu-
bules with slow subunit turnover upon long polymer expo-
sure to an ill-defined carboxypeptidase (for reviews see
Barra et al., 1988; MacRae, 1997). Neuronal tissues con-
tain large amounts of Glu-tubulin (Fig. 4 A; Baas and
Black, 1990; Paturle-Lafanechère et al., 1994). Such an ac-
cumulation of Glu-tubulin also occurs in differentiating
DRG cells (Fig. 4 A).
Differentiated DRG cells, untreated or exposed to cold
temperature, were compared for microtubule content in
Glu-tubulin. Cold-treated and control DRG cells were im-
munostained with a Glu-tubulin antibody and further pro-
cessed for electron microscopy. Microtubule labeling was
quantified on distal sections of DRG cell axons. In control
cells, microtubules (total microtubules) were decorated on
average with 11.0 6 0.2 gold particles per 500 nm of poly-
mer length (Table I). In cells exposed to cold temperature,
microtubules (cold-stable microtubules) were associated
Figure 3. Immunolocalization of STOP proteins in DRG cell ax-
ons. After 10 d of culture, DRG cells were stained using the affin-
ity-purified 23C STOP antibody and a Cy3- (A) or gold-labeled
(B) secondary antibody. (A) Immunofluorescence analysis of
STOP localization in DRG cell axons. Bar, 25 mm. (B) Immuno-
electron microscopy of a DRG cell axon: microtubules were spe-
cifically decorated with gold particles. Bar, 50 nm. (C) Gold parti-
cle distribution along axonal microtubules in the distal part of
DRG cell axons. (Black bars) total microtubules; (dark gray bars)
cold stable microtubules; (light gray bars) nocodazole-resistant
microtubules. In control experiments with secondary antibody
alone, microtubules were never decorated with more than four
gold particles.
Table I. STOP and Tubulin Labeling of Microtubules in DRG 
Cell Axons
STOP Glu-tubulin Tyr-tubulin D2-tubulin
T MTs
m 12.8 11.0 21.4 19.3
SEM 0.3 0.2 0.6 0.5
n 523 397 333 376
CS MTs
m 21.4 21.3 17.0 21.9
SEM 0.6 0.5 0.5 0.6
n 295 261 167.0 236.0
CL MTs
m 4.2 0.7 25.8 16.7
SEM 0.8 0.6 1.3 1.2
DRG cells were either untreated or exposed to cold temperature. Cells were further
reacted either with the affinity-purified 23C STOP antibody or with one isoform spe-
cific tubulin antibody (Tyr-, Glu- or D2-tubulin antibody) and with secondary
gold-labeled antibody. The table shows the mean numbers of gold particles observed
per 500 nm of microtubule length for total (T MTs) and cold-stable (CS MTs) poly-
mers. The corresponding mean numbers for cold-labile microtubules (CL MTs) were
estimated as described under Materials and Methods. m, mean number of gold particle
per 500 nm of microtubule length. SEM, standard error of the mean. n, number of mi-
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with an average number of 21.3 6 0.5 gold particles per
500 nm of polymer length (Table I). From these values,
the expected mean number of gold particles per 500 nm of
polymer length for cold-labile microtubules was estimated
to be 0.7 6 0.6 (Table I). These results indicate a very
strong association between microtubule cold stability and
microtubule detyrosination in DRG cell axons. This dety-
rosination of cold-stable microtubules was also evident
from the quantification of Tyr-tubulin labeling among the
total, cold-stable, and cold-labile polymer populations:
cold-stable microtubules contained less Tyr-tubulin than
did total or cold-labile microtubules (Table I).
Besides Tyr- and Glu-tubulin, neurons specifically contain
a third tubulin variant, D2-tubulin (Paturle-Lafanechère et
al., 1994). D2-tubulin differs from Tyr-tubulin by the dele-
tion of the last two COOH-terminal amino acids of a-tubu-
lin (Paturle-Lafanechère et al., 1991). D2-tubulin only ap-
pears on very long-lived polymers, and is absent in
nonneuronal cells (Paturle-Lafanechère et al., 1994).
DRG cells accumulated D2-tubulin during differentiation
(Fig. 4 A). D2-tubulin was present along the whole axon
(Fig. 4 B), and only moderately enriched in cold-stable mi-
crotubules (Table I).
STOP Expression and Tubulin Modification in 
PC12 Cells
In the preceding sections it was shown that microtubule
association with STOP proteins and microtubule stabiliza-
tion are two tightly associated polymer properties. STOP
may associate with microtubules stabilized by other fac-
tors, or STOP may cause microtubule stabilization. To test
which of these possibilities was correct, we assessed the ef-
fect of STOP inhibition on microtubule stability in neu-
ronal cells. To do this, a neuronal cell system amenable to
routine examination of microinjection or antisense experi-
ments was required. We chose PC12 cells, as these cells
can be grown indefinitely in vitro in the absence of NGF
and undergo neuronal differentiation upon exposure to
NGF (Greene and Tischler, 1976). To assess the utility of
PC12 cells as a cell model in the context of the present
study, they were examined for STOP expression and tubu-
lin modification during differentiation.
As in the case of DRG cells, STOP expression in PC12
cells was analyzed on immunoblots using three different
STOP antibodies. Results observed using the 23C STOP
antibody are shown in Fig. 5 A. Identical results were ob-
served with the 23N STOP antibody (data not shown). 10
d–differentiated PC12 cells expressed adult STOP, E-STOP,
and two additional STOP-reactive polypeptides of 45 kD
and 100 kD. Recent work in this laboratory has shown that
the 45-kD and 100-kD reactive polypeptides correspond to
STOP proteins normally expressed in certain nonneuronal
tissues. The complete molecular and functional character-
ization of nonneuronal STOP proteins will be presented in
a forthcoming article (Denarier et al., 1998b). For the pur-
pose of the present study, the important fact was that dif-
ferentiated PC12 cells expressed STOP proteins. Differen-
tiated PC12 cells also contained Glu- and D2-tubulin (Fig. 5
B). To assess the NGF dependence of STOP and D2-tubu-
lin accumulation in PC12 cells, we used immunufluores-
cence analysis. Mixed populations of differentiated and
undifferentiated PC12 cells were stained either with 23C
STOP antibody or with D2-tubulin antibodies. Differenti-
ated PC12 cells exhibited bright staining of neurite exten-
sions with both antibodies, while undifferentiated cells
showed low or background levels of staining (Fig. 5, C and
D). These results indicate that, with respect to STOP ex-
pression and tubulin modification, the behavior of NGF-
treated PC12 cells is similar to that of other neuronal cell
models.
STOP Proteins are Responsible for Microtubule Cold
and Drug Stability in Differentiated PC12 Cells
To test whether the demonstrated STOP association with
microtubules was indeed responsible for microtubule sta-
bilization, we examined the effect of STOP inactivation on
microtubule stability in PC12 cells. Fused PC12 cells (Okabe
and Hirokawa, 1988) were injected either with affinity-
purified STOP antibody (23C or 23N) or with control
IgGs.  STOP central repeat antibodies have the capacity to
inhibit STOP binding to microtubules in vitro (Fig. 6). Af-
ter a recovery period of 6 h, cells were assayed for micro-
tubule resistance to depolymerizing conditions (exposure
to cold temperature or to nocodazole). For microtubule
content assay, cells were lysed in a large volume of Triton-
Pipes buffer to remove free tubulin dimers, and polymeric
tubulin was subsequently visualized by immunofluores-
cence microscopy with tubulin antibody (for details see
Materials and Methods and Lieuvin et al., 1994). To iden-
tify microinjected cells among other cells, microinjected
control IgGs or microinjected STOP antibody were visual-
ized with Cy3-conjugated rabbit IgG antibody (Fig. 7, A–C
and G–I, respectively).
In the absence of cold or nocodazole treatment, PC12
cells microinjected with nonreactive IgGs showed bright
microtubule signal after staining with tubulin antibody
(Fig. 7 D). The microtubule signal was not evidently modi-
Figure 4. Tubulin modification in DRG cells. (A) Immunoblot
analysis of tubulin modification in DRG cells: proteins from
DRG cells cultured for 3 d (lane 1) or 10 d (lane 2), adult rat
brains (lane 3), and embryonic rat brains (lane 4) were run on
7.5% SDS gels. Amounts of loaded proteins were as indicated in
the legend to Fig. 1 A. Proteins were immunoblotted with iso-
form-specific tubulin antibodies as indicated. (B) Immunofluo-
rescence analysis of D2-tubulin localization in 10-d cultured DRG
cell axons. Cells were reacted with a specific D2-tubulin antibody.
Axons showed bright and apparently homogeneous D2-tubulin
staining along their length. Bar, 25 mm.The Journal of Cell Biology, Volume 142, 1998 174
fied when such microinjected cells were exposed to cold
temperature or to nocodazole before assay of microtubule
content (Fig. 7, E and F, respectively). Nonmicroinjected
cells behaved in the same manner as cells injected with
nonreactive IgGs (data not shown). These results demon-
strate that PC12 cells contain an abundant subset of cold-
and drug-resistant microtubules, and that microtubule sta-
bility is not modified by the microinjection process.
In the absence of cold or nocodazole treatment, cells mi-
croinjected with affinity-purified 23C STOP antibody
showed apparently normal microtubule signal when
stained with tubulin antibody (Fig. 7 J). However, expo-
sure of such cells to cold temperature or to nocodazole
induced complete microtubule disassembly, as shown by
absence of detectable microtubule signal in cold- or drug-
treated cells (Fig. 7, K and L, respectively). The absence of
microtubules in cold-treated STOP antibody–injected cells
was also evident in electron micrographs of microinjected
cells processed for electron microscopy as in Yu and Baas
(1995; data not shown). Thus, injection of the STOP anti-
body into PC12 cells abolished microtubule cold and drug
stability. These striking results were highly reproducible,
being observed in all STOP antibody–microinjected cells.
Results were identical when affinity-purified 23N antibody
was used instead of affinity-purified 23C antibody (data
not shown). These results provide compelling evidence
that STOP proteins are major determinants of microtu-
bule cold and drug stability in differentiated PC12 cells.
Effect of STOP Inhibition on Neurite Formation in 
PC12 Cells
There is evidence that cold- and drug-stable polymers are
required for neurite integrity (Baas and Heidemann, 1986;
Baas and Black, 1990; Baas and Ahmad, 1992). However,
such stable polymers may not be required for maintaining
preexisting neurites; differentiated PC12 cells microin-
jected with STOP antibody lack cold- and drug-stable
polymers, and nevertheless retain apparently normal
neurite extensions (Fig. 7, G–L). We have repeated such
experiments with variable delays (2–30 h) between cell mi-
croinjection and cell examination. In all STOP antibody–
microinjected cells, neurite extensions remained appar-
ently normal, while microtubule cold and drug stability
was abolished (data not shown). Therefore, at least within
the time duration of our experiments, STOP activity was
not required for maintenance of preexisting neurites.
We tested to see whether STOP proteins were required
for neurite outgrowth in PC12 cells that were not yet mor-
phologically differentiated. For STOP inhibition, we used
Figure 5. STOP expression and tubulin
modification in PC12 cells. (A) Immuno-
blot analysis of STOP expression in PC12
cells: proteins from PC12 cells after 10 d of
differentiation (lane 1), adult rat brains
(lane  2), and embryonic rat brains (lane 3)
were run on 7.5% SDS gels. 20 mg of PC12
cell proteins were loaded onto the gel.
Amounts of loaded brain proteins were
adjusted to equilibrate brain and PC12 cell
STOP signals. Proteins were immunoblot-
ted with polyclonal STOP antibody 23C.
Superimposable results were observed
with the 23N STOP antibody (data not
shown). The bands corresponding to
STOP and E-STOP are indicated. Size
markers are in kD. (B) Immunoblot anal-
ysis of tubulin modification in PC12 cells:
proteins from PC12 cells after 10 d of dif-
ferentiation (lane 1), adult rat brains (lane
2), and embryonic rat brains (lane 3) were
run on 7.5% SDS gels. Amounts of loaded
proteins were as indicated in A. Proteins
were immunoblotted with isoform-specific
tubulin antibodies as indicated. (C and D)
Immunofluorescence analysis of mixed populations of differentiated and undifferentiated PC12 cells with 23C STOP antibody (C) or
D2-tubulin antibody (D). Neurite extensions in differentiated cells showed bright STOP or D2-tubulin staining while undifferentiated
cells showed low or background levels of staining. Bar, 50 mm.
Figure 6. In vitro inhibition
of E-STOP binding to micro-
tubules by STOP antibody.
In vitro–translated E-STOP
(35S-labeled) was sedimented
in the presence of bovine
brain–polymerized microtu-
bules (for details see Materi-
als and Methods) after prein-
cubation (5 min, 378C) with
polyclonal STOP antibody 23C (0.20 mg/ml) or with naive IgGs
at the same concentration, as indicated. Equal amounts of the
pellet (P) and supernatant (S) were separated by 7.5% SDS/
PAGE and exposed to autoradiography. In the presence of
STOP antibody 23C, extensive inhibition of E-STOP binding to
microtubules was observed. Results were similar when E-STOP
solutions were preincubated with microtubules before adding
STOP antibody 23C, and when STOP antibody 23C was replaced
by STOP antibody 23N (data not shown). Size markers are in kD.Guillaud et al. STOP and Microtubule Stabilization in Neurons 175
both microinjection of STOP antibodies and cell exposure
to STOP antisense oligonucleotides. In microinjection ex-
periments, fused PC12 cells were injected either with affin-
ity-purified 23C STOP antibodies or with naive IgGs. Mi-
croinjected cells were then grown in the presence of NGF
for 36 h and examined for the presence of neurite exten-
sions. Cells were scored as positive if they exhibited exten-
sions longer than one cell body diameter. Pooled data
from two independent experiments showed that 33 6 3%
(n 5 200) of the cells injected with nonspecific IgGs had
significant neurite extensions at the time of examination.
Such a yield of cell differentiation was similar to that rou-
tinely observed in nonmicroinjected fused PC12 cells. In
contrast, only 14 6 3% (n 5 183) of the cells microinjected
with the 23C STOP antibody had neurites at the time of
examination. This twofold difference between the ob-
served percentages was highly significant (P , 0.001).
Microinjection experiments involve the use of fused
PC12 cells. Such cells show a relatively low yield of differ-
entiation. STOP effect on neurite formation was also ex-
amined in normal PC12 cells treated with antisense oligo-
nucleotides using DOTAP as transfection reagent. We
tested five different antisense oligonucleotides derived
from the STOP cDNA sequence coding for the STOP cen-
Figure 7. STOP inhibition
suppresses microtubule cold
and drug stability in fused PC
12 cells Fused PC12 cells
injected with control IgGs
(A–F) showing IgG (A–C)
and microtubule (D–F) stain-
ing. (A and D) Untreated
cells; (B and E) cold-treated
cells; (C and F) nocodazole-
treated cells. Fused PC12
cells injected with affinity-
purified 23C STOP antibody
(G–L) showing STOP anti-
body (G–I) and microtubule
(J–L) staining. (G and J) Un-
treated cells; (H and K) cold-
treated cells; (I and L) no-
codazole-treated cells. Note
that after cell lysis, enough
microinjected IgGs remain
associated with insoluble cell
structures to allow clear
identification of injected
cells. STOP antibody injec-
tion suppressed microtubule
cold and drug stability. Bar,
50 mm.The Journal of Cell Biology, Volume 142, 1998 176
tral repeats. In control experiments, the corresponding
sense and scrambled oligonucleotides were also tested for
their effect on PC12 cell differentiation. In the presence of
DOTAP alone, z80% of PC12 cells had significant neu-
rite extensions after a 36-h treatment with NGF. In the
presence of the different added antisense oligonucleotides,
only 18–45% of the cells had significant neurite extensions
at the time of examination (Fig. 8, A–C). Such a decrease
was never observed in cells treated with sense or scram-
bled oligonucleotides (Fig. 8 C). Upon immunofluores-
cence examination, the cells that had grown neurites de-
spite exposure to antisense oligonucleotides exhibited
STOP staining in neurites, while other cells showed low or
background levels of staining (data not shown). Immuno-
blot analysis confirmed strong inhibition of STOP expres-
sion in the presence of antisense oligonucleotides (Fig. 8 D).
In conclusion, we find extensive and specific inhibition
of neurite outgrowth in PC12 cells upon microinjection of
STOP antibody or cell exposure to five different STOP an-
tisense oligonucleotides. These results strongly suggest that
STOP activity is required for normal neurite formation.
Discussion
STOP Proteins, Microtubule Stability, and 
Microtubule Turnover
It has been known for many years that neurons contain
abundant subsets of cold-stable microtubules (Webb and
Wilson, 1980; Morris and Lasek, 1982; Black et al., 1984;
Brady et al., 1984; Baas et al., 1994). Cold stability is a re-
markable property of neuronal microtubules, in sharp con-
trast with the lability of microtubules assembled from pure
tubulin in vitro. However, the origin of microtubule cold
stabilization in neurons has remained obscure (Baas et al.,
1994). Neuronal microtubules interact with many cell com-
ponents, and it has been uncertain whether cold stability
resulted from the action of a single well-defined effector,
or had a multiplicity of causes. Among possible factors in-
volved in microtubule cold stabilization, STOP, a neuronal
calmodulin- and microtubule-binding protein, was of par-
ticular interest because of its capacity to induce microtu-
bule cold stability (Bosc et al., 1996). Here we find that dif-
ferentiating neuronal cells express several STOP variants.
Examination of the STOP distribution at the ultrastructural
level in DRG cells shows STOP presence along micro-
tubules and specifically among cold-stable microtubules.
Microinjection of STOP antibodies into differentiated
PC12 cells causes complete suppression of microtubule
cold stability. These results demonstrate that microtubule
cold stability in neuronal cells is due to lengthwise associa-
tion of microtubules with STOP proteins.
Cold stability is not the only remarkable stability prop-
erty of neuronal microtubules. Although microtubules in
cycling cells are universally sensitive to nocodazole, neu-
ronal microtubules are in large part drug-resistant. Before
this study it was unclear whether cold stability and drug re-
sistance were independent or related properties of neu-
ronal microtubules (Baas et al., 1994). There is evidence
that several MAPs such as MAP2, MAP1B, and tau may
be involved in the induction of microtubule drug resis-
tance in neurons (Takemura et al., 1992, Baas et al., 1994),
Figure 8. Inhibition of neu-
rite formation in PC12 cells
treated with STOP antisense
oligonucleotides. (A and B )
Immunofluorescence analy-
sis of PC12 cells after a 36-h
NGF treatment in the pres-
ence of sense ON4 (A) or an-
tisense ON4 (B). For visual-
ization of neurite extensions,
cells were stained with mAb
TUB 2.1 tubulin antibody.
Bar, 100 mm. (C) Effect of
five different STOP anti-
sense oligonucleotides on
neurite outgrowth. Each an-
tisense oligonucleotide (as)
was tested in parallel with
the corresponding sense (se)
and scrambled (sc) oligonu-
cleotides. ON1–ON5 desig-
nate the five groups of oligo-
nucleotides tested. In each
condition, the proportion of
differentiated cells among
the total cell population was
determined. Results are ex-
pressed as percent of control values determined in the presence of DOTAP alone (for details see Materials and Methods). (D) Immuno-
blot analysis of STOP proteins in PC12 cells after a 3-d NGF treatment in the presence of DOTAP alone (c), antisense (as), sense (se),
or scrambled (sc) oligonucleotide ON4. 20 mg of PC12 cell proteins were loaded on 7.5% SDS gels. Proteins were immunoblotted with
polyclonal STOP antibody 23C. Results marked diminution of STOP expression in cells treated with antisense oligonucleotide ON4.
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while such MAPs are devoid of cold-stabilizing activity
(Pirollet et al., 1983; Baas et al., 1994). As STOP has the
capacity to inhibit nocodazole action (Bosc et al., 1996),
we have examined STOP contribution to the generation of
microtubule resistance to drugs in neurons. We find that
drug-resistant microtubules in DRG cells are highly en-
riched in STOP proteins. Moreover, microinjection of
STOP antibodies in PC12 cells abolishes microtubule re-
sistance to nocodazole. This is compelling evidence that
STOP proteins are major factors controlling both microtu-
bule cold and drug stability in neurons.
The observation of extensive microtubule drug resis-
tance in neurons has suggested that microtubule turnover
may be slow in these cells. Direct measurements of micro-
tubule turnover have shown that a large subset of microtu-
bules requires hours to turn over in neurons instead of a
time course of minutes in other cell types (Lim et al., 1989;
Okabe and Hirokawa, 1990; Takeda et al., 1995; Li and
Black, 1996). Recently, such measurements have also pro-
vided a direct demonstration that there is a strong correla-
tion between slow microtubule turnover and microtubule
detyrosination in neuronal cells (Li and Black, 1996) as
predicted from experiments previously done in other cell
types (Kreis, 1987; Schulze et al., 1987; Wehland and We-
ber, 1987; Bulinski and Gundersen, 1991). In DRG cells,
we find that cold-stable (STOP-associated) microtubules
are heavily enriched in Glu-tubulin as compared with
cold-labile microtubules. We could not test whether STOP
inhibition suppresses microtubule detyrosination in PC12
cells. Such a test would have involved microinjection of
STOP antibodies followed by Glu-tubulin immunostaining.
As both STOP and Glu-tubulin antibodies are rabbit poly-
clonal antibodies, double-labeling experiments were diffi-
cult. However, the tight association between microtubule
cold stability and microtubule detyrosination in DRG cells
strongly suggests that STOP proteins are major effectors of
microtubule dynamics in unperturbed neuronal cells.
When compared with cold-labile microtubules, cold-sta-
ble microtubules are much more enriched in Glu-tubulin
than in D2-tubulin. This finding may seem paradoxical in
view of previous evidence that D2-tubulin appears only on
very long-lived microtubules (Paturle-Lafanechère et al.,
1994). The most probable explanation is that in contrast
with Glu-tubulin dimers, D2-tubulin dimers persist after
dissociation from polymers. After polymer dissociation,
Glu-tubulin is rapidly converted back to Tyr-tubulin upon
action of a tubulin-tyrosine-ligase (MacRae, 1997). In con-
trast, generation of D2-tubulin almost certainly results
from an irreversible set of enzymatic reactions (Paturle-
Lafanechère et al., 1994). The free D2-tubulin dimers can
therefore be incorporated into newly forming polymers.
Our observation of an almost even distribution of D2-tubu-
lin along axons and among axonal microtubules indicates
continuous reshuffling of tubulin subunits among axonal
polymers. This is in agreement with recent evidence that
microtubules continuously exchange their constitutive tu-
bulin subunits with the tubulin molecules of the soluble
pool during their migration in axons (Okabe and Hi-
rokawa, 1990; Okabe and Hirokawa, 1992; Funakoshi et al.,
1996; Yu et al., 1996).
Taken together, our results show that microtubule stabi-
lization in neurons mainly results from the action of STOP
proteins. Apparently, as long as they are associated with
active STOP proteins, microtubules are cold-stable, drug-
resistant, and become detyrosinated. Over time, STOP ac-
tivity varies through action of regulatory effectors (Job et al.,
1981; Job et al., 1983). Such regulation probably accounts
for the lower proportion of nocodazole-resistant microtu-
bules compared with the proportion of cold-stable micro-
tubules in neuronal cells. We surmise that, during the no-
codazole test, some initially stable polymers may lose
stability as a result of STOP regulation, and will therefore
depolymerize.
STOP Isoforms and Neuronal Differentiation
The present study suggests a tight relationship between
STOP expression and neuronal differentiation. DRG and
PC12 cells, which are of different origins, both show STOP
expression during differentiation. Furthermore, STOP ex-
pression is also tightly related to neuronal differentiation
in developing rat cerebellum. This study also demonstrates
the existence of STOP variants that seem to be expressed
differentially according to the stage of neuronal differenti-
ation.  We have previously described the structure of
STOP from adult rat brain. In the present study we have
characterized a major STOP variant, E-STOP. E-STOP is
the principal STOP protein present in embryonic brain,
and differs from adult STOP by the presence of one addi-
tional central repeat and deletion of the adult STOP car-
boxy-terminal repeat domain. Recent work in this labora-
tory has shown that there are actually multiple developmental
and/or cell-specific STOP isoforms. In mice, STOP iso-
forms are generated from a single gene (Denarier et al.,
1998a) through differential RNA splicing and alternative
transcription start sites (Denarier et al., 1998b). The
mouse STOP gene is comprised of four exons (Denarier et
al., 1998a). The coding sequence of the E-STOP cDNA
terminates at a location corresponding exactly to the end
of exon 3 in the mouse gene. Exon 4, which is lacking in
the E-STOP cDNA, encodes the COOH-terminal STOP
repeats in adult STOP. E-STOP has calmodulin- and mi-
crotubule-binding activity comparable to the complete
adult STOP. Therefore, the COOH-terminal repeat do-
main of STOP is not essential for these aspects of STOP
function. This domain may interact with cellular compo-
nents other than microtubules and calmodulin, and we are
currently investigating this possibility.
STOP Proteins and Neurite Formation
We find that in differentiated PC12 cells, STOP inhibition
does not induce immediate and obvious neurite retraction.
Clearly, neurites can survive in the absence of fully stabi-
lized microtubules, at least within the time duration of our
experiments. In contrast, STOP proteins are apparently
required for induction of neurite formation in cells that
have not differentiated before STOP inhibition. STOP in-
hibition may either directly affect the mechanics of neurite
formation, or may have a more general effect on cell dif-
ferentiation. Induction of cell differentiation by NGF
could depend on adapted regulation of cytoskeletal dy-
namics. In the absence of STOP activity, such regulation
may be perturbed.
Neurons contain several classes of MAPs whose activityThe Journal of Cell Biology, Volume 142, 1998 178
is central to neuronal morphogenesis and function (for re-
views see Hirokawa, 1994; Mandelkow and Mandelkow,
1995). Antisense oligonucleotides directed against MAP2,
MAP1B, and tau have an inhibitory effect similar to STOP
antisense oligonucleotides with regard to neurite forma-
tion (Hanemaaijer and Ginzburg, 1991; Caceres et al.,
1992; Shea et al., 1992; Brugg et al., 1993; Esmaeli-Azad
et al., 1994; Sharma et al., 1994). Tau antisense oligonucle-
otides also trigger neurite retraction (Hanemaaijer and
Ginzburg, 1991; Shea et al., 1992). Such an effect on neu-
rite maintenance is absent in the case of MAP1B antisense
oligonucleotides (Brugg et al., 1993) and only detectable
using refined morphometric analysis in the case of MAP2
antisense oligonucleotides (Sharma et al., 1994).
An integrated view of microtubule regulation in neu-
rons will require an understanding of the cooperative ef-
fects of all the various neuronal MAPs. However, com-
plete suppression of microtubule cold stability and drug
resistance after STOP inhibition in neuronal cells suggests
that STOP proteins are unique with regard to their micro-
tubule-stabilizing effect, and cannot be replaced by other
MAPs. Because of this apparent absence of redundancy of
the STOP system, the STOP gene knockout should yield
clear-cut phenotypes. The suppression of STOP expres-
sion in whole animals should determine whether microtu-
bule stabilization by STOP proteins is indispensable to
normal neuronal differentiation, as suggested by the re-
sults of the present study.
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